Last reviewed · How we verify
Measles-Rubella vaccine Bio Farma — Competitive Intelligence Brief
phase 2
Biologic
Live · refreshed every 30 min
Target snapshot
Measles-Rubella vaccine Bio Farma (Measles-Rubella vaccine Bio Farma) — PT Bio Farma.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Measles-Rubella vaccine Bio Farma TARGET | Measles-Rubella vaccine Bio Farma | PT Bio Farma | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Measles-Rubella vaccine Bio Farma CI watch — RSS
- Measles-Rubella vaccine Bio Farma CI watch — Atom
- Measles-Rubella vaccine Bio Farma CI watch — JSON
- Measles-Rubella vaccine Bio Farma alone — RSS
Cite this brief
Drug Landscape (2026). Measles-Rubella vaccine Bio Farma — Competitive Intelligence Brief. https://druglandscape.com/ci/measles-rubella-vaccine-bio-farma. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab